Italian CDMO and API supplier Olon has presented a two-year, €30 million plan to expand its Settimo Torinese Biotech Hub near Turin. This focuses on microbial fermentation and is claimed to have “some of the most extensive know-how” on the subject in Europe”. The plan focuses on therapeutic peptides based on Olon’s expertise in the development of rDNA peptides and proteins.

Italian firm Olon has presented its new division, Olon Biotech, which will offer CDMO services at industrial scale. These based on microbial fermentation processes using bacteria, yeast and fungi and will include high potency. It will also have proprietary products for industries including health and pharma, food, cosmetics, flavours and fragrances.